Photo: Kevin Light

Jiu-Jitsu champion Robert Drysdale has been declined by the Nevada State Athletic Commission to compete at next month’s UFC 167 event after an out-of-competition drug test revealed an elevated testosterone-to-epitestosterone (T/E) ratio.

Drysdale is a world class grappler who achieved a gold medal in the 2007 Abu Dhabi Submission Wrestling World Championship. He focused on MMA and made his professional debut in 2010, where he built up a record of 6-0 before getting signed by the UFC.

Drysdale is 6-0 MMA, 0-0 UFC was scheduled to meet light heavyweight Cody Donovan in theUFC’s  Nov. 16 event. Drysdale was caught with a 19.4-1 T/E ratio, which is more than three times the NSAC’s 6-1 limit.

MMA Junkie also reported that Drysdale had filed a request for a therapeutic use exemption (TUE) for testosterone replacement therapy (TRT) prior to his originally scheduled fight at UFC 163:

Less than a month before his scheduled UFC debut at UFC 163 against Ednaldo Oliveira earlier this year, he submitted paperwork to obtain a therapeutic-use exemption (TUE) to undergo testosterone-replacement therapy (TRT), according to documents MMAjunkie.com obtained through a public records request.

On his application, which is dated July 8, 2013, the 32-year-old Drysdale stated the TUE request was his first. He certified that he hadn’t used or was currently using banned substances and had no previous positive tests. Also included in the paperwork was a letter from a Las Vegas-based anti-aging clinic, TrimBody M.D., that stated Drysdale was taking weekly testosterone injections at the clinic to treat hypogonadism.

Additionally, a blood exam from Clinical Pathology Laboratories showed Drysdale had a free testosterone level of 156 ng/mL, which was below the testing facility’s normal range of 292 ng/mL to 1052 ng/mL. He was within the laboratory’s normal range for follicle-stimulating hormone (6.0 mIU/mL) and luteinizing hormone (2.1 mIU/mL).